Melphalan flufenamide
Alkylating Drug — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: CK 1535, J1, melflufen, melphalan flufenamide hydrochloride, pepaxto
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Melphalan flufenamide is an ofm drug in the Alkylating Drug class catalogued in DrugCentral. It was first approved by the FDA in 2021. Its mechanism of action is classified as Alkylating Activity. Recorded indications include Relapsed or refractory multiple myeloma.
- Approval status: ofm (first approved 2021 by the FDA).
- Drug class: Alkylating Drug.
- Mechanism of action: Alkylating Activity.
- Indications: Relapsed or refractory multiple myeloma.
- ATC code: L01AA10 (Nitrogen mustard analogues).
- Molecular formula: C24H30Cl2FN3O3; molecular weight 498.42 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Relapsed or refractory multiple myeloma
Contraindications (1)
- Breastfeeding (mother)
Mechanism & targets
| Mechanism of action (MoA) | Alkylating Activity |
|---|---|
| Established pharmacologic class | Alkylating Drug |
Regulatory approvals (2)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2022-08-17 | EMA | — | ONCOPEPTIDES AB | Yes |
| 2021-02-26 | FDA | — | ONCOPEPTIDES AB | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01AA10 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Nitrogen mustard analogues |
Chemical structure
| Molecular formula | C24H30Cl2FN3O3 |
|---|---|
| Molecular weight | 498.42 g/mol |
| CAS number | 380449-51-4 |
| InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |
| PubChem CID | 9935639 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Melphalan flufenamide used for?
DrugCentral lists the following indications for Melphalan flufenamide: Relapsed or refractory multiple myeloma.
How does Melphalan flufenamide work?
Melphalan flufenamide is classified as Alkylating Activity.
When was Melphalan flufenamide first approved?
Melphalan flufenamide was first approved by the FDA in 2021.
What drug class does Melphalan flufenamide belong to?
Melphalan flufenamide is in the Alkylating Drug class.
What is the chemical formula of Melphalan flufenamide?
Melphalan flufenamide has the molecular formula C24H30Cl2FN3O3 and a molecular weight of 498.42 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5445 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL4297403 — compound record and bioactivity
- PubChem CID 9935639 — chemical identifiers
- DrugBank DB16627 — drug record
- FDA UNII F70C5K4786 — substance identity
- DailyMed: FDA labels for Melphalan flufenamide — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.